Industries > Pharma > Batten Disease Treatment Market Report to 2031
Batten Disease Treatment Market Report to 2031
By Disease Type (Late Infantile NCL, Juvenile NCL, Adult NCL), By Therapy (Occupational Therapy, Physical Therapy), and Leading Regional/ Country Market Analysis
Global Batten Disease Treatment Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Global Batten Disease Treatment Market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our Global Batten Disease Treatment page report provides tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Global Batten Disease Treatment Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analysis (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and recent developments.
Discover sales predictions for the world market and submarkets
Global Batten Disease Treatment: By Disease Type
• Late Infantile NCL
• Juvenile NCL
• Adult NCL
Global Batten Disease Treatment: By Therapy
• Occupational Therapy
• Physical Therapy
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Global Batten Disease Treatment Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Global Batten Disease Treatment Market will surpass $XXX million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Global Batten Disease Treatment Market report helps you
In summary, our 280+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Global Batten Disease Treatment Market, with forecasts for Disease Type, Therapy, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Global Batten Disease Treatment Market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for Global Batten Disease Treatment of the major companies involved in the Global Batten Disease Treatment Market. Some of the company’s profiled in this report include ReGenX Biosciences LLC, BioMarin Pharmaceuticals, Seneb BioSciences Inc., Amicus Therapeutics, Abeona Therapeutics, Polaryx Therapeutics, Theranexus, Recursion Pharmaceuticals, Sanofi, Takeda Pharmaceuticals, StemCells, Inc., Antech Diagnostics, Neurogene Inc., Celgene Corp, Raptor Pharmaceutical Corp, among others.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Global Batten Disease Treatment Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Batten Disease Treatment Market Report to 2031: By Disease Type (Late Infantile NCL, Juvenile NCL, Adult NCL), By Therapy (Occupational Therapy, Physical Therapy), and Leading Regional/ Country Market Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Batten Disease Treatment Market
2.1. Batten Disease Treatment Market Definition
2.2. Disease Type Submarkets Definitions
2.3. Therapy Submarkets Definitions
3. Batten Disease Treatment Market Overview
3.1. Global Batten Disease Treatment Market Size and Forecast by Region
3.2. Global Batten Disease Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising incidence and prevalence rate of batten disease
3.3.1.2. Robust investment in R&D
3.3.1.3. Cohesive government policies and initiatives
3.3.1.4. Technological Advancement and innovation
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost of Treatment and Therapies
3.3.2.2. Low awareness
3.3.3. Opportunities
3.3.3.1. Cohesive reimbursement policies
3.3.3.2. Healthcare reforms in emerging economies
3.3.3.3. Growing disposable income
4. Global Batten Disease Treatment Market Analysis and Forecast 2021-2031, by Disease Type(Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Late Infantile NCL
4.1.2. Juvenile NCL
4.1.3. Adult NCL
5. Global Batten Disease Treatment Market Analysis and Forecast, 2021-2031 by Therapy (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Occupational Therapy
5.1.2. Physical Therapy
6. North America Batten Disease Treatment Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Batten Disease Treatment Market Size and Forecast by Disease Type
6.3. North America Batten Disease Treatment Market Size and Forecast by Therapy
6.4. U.S. Batten Disease Treatment Market
6.4.1. Growing Incidence and Prevalence Rate of Batten Disease
6.5. Canada Batten Disease Treatment Market
6.5.1. Cohesive Healthcare Policies
7. Europe Batten Disease Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Batten Disease Treatment Market Size and Forecast by Disease Type
7.3. Europe Batten Disease Treatment Market Size and Forecast by Therapy
7.4. UK Batten Disease Treatment Market
7.5. Germany Batten Disease Treatment Market
7.6. France Batten Disease Treatment Market
7.7. Rest of Europe Batten Disease Treatment Market
8. Asia Pacific Batten Disease Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Batten Disease Treatment Market Size and Forecast by Disease Type
8.3. Asia Pacific Batten Disease Treatment Market Size and Forecast by Therapy
8.4. China Batten Disease Treatment Market
8.5. India Batten Disease Treatment Market
8.6. Japan Batten Disease Treatment Market
8.7. Rest of Asia Pacific Batten Disease Treatment Market
9. Latin America Batten Disease Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Batten Disease Treatment Market Size and Forecast by Disease Type
9.3. Latin America Batten Disease Treatment Market Size and Forecast by Therapy
9.3.1. Brazil Batten Disease Treatment Market
9.3.2. Mexico Batten Disease Treatment Market
9.3.3. Rest of Latin America Batten Disease Treatment Market
10. MEA Batten Disease Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Batten Disease Treatment Market Size and Forecast by Disease Type
10.3. MEA Batten Disease Treatment Market Size and Forecast by Therapy
10.4. GCC Batten Disease Treatment Market
10.5. South Africa Batten Disease Treatment Market
10.6. Rest of MEA Batten Disease Treatment Market
11. Companies in the Batten Disease Treatment Market
11.1. ReGenX Biosciences LLC
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial (2016-2020)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2020
11.1.4. Product Offerings
11.1.5. Recent Initiatives (2017-2020)
11.2. BioMarin Pharmaceuticals
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2020)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2020
11.2.4. Product Offerings
11.2.5. Recent Initiatives (2017-2020)
11.3. Seneb BioSciences Inc.
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2020)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2020
11.3.4. Product Offerings
11.3.5. Recent Initiatives (2017-2020)
11.4. Amicus Therapeutics
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance (2015-2020)
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue, 2020
11.4.4. Product Offerings
11.4.5. Recent Initiatives (2017-2020)
11.5. Abeona Therapeutics
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance (2015-2020)
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue, 2020
11.5.4. Product Offerings
11.5.5. Recent Initiatives (2017-2020)
11.6. Polaryx Therapeutics
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance (2015-2020)
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue, 2020
11.6.4. Product Offerings
11.6.5. Recent Initiatives (2017-2020)
11.7. Theranexus
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance (2015-2020)
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue, 2020
11.7.4. Product Offerings
11.7.5. Recent Initiatives (2017-2020)
11.8. Recursion Pharmaceuticals
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance (2015-2020)
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue, 2020
11.8.4. Product Offerings
11.8.5. Recent Initiatives (2017-2020)
11.9. Sanofi
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance (2015-2020)
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue, 2020
11.9.4. Product Offerings
11.9.5. Recent Initiatives (2017-2020)
11.10. Takeda Pharmaceuticals
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance (2015-2020)
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue, 2020
11.10.4. Product Offerings
11.10.5. Recent Initiatives (2017-2020)
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Type
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation Type
LIST OF TABLES
Table 1. Batten Disease Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Batten Disease Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Batten Disease Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Batten Disease Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Batten Disease Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Batten Disease Treatment Market Drivers & Restraints 2021
Table 7. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 13. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Juvenile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Juvenile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Juvenile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Juvenile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Juvenile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Adult NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Adult NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Adult NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Adult NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Adult NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 28. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Occupational Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Occupational Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Occupational Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Occupational Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Occupational Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Physical Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Physical Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Physical Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Physical Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Physical Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Regional Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 43. Regional Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Regional Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Regional Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Regional Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 47. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 48. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 49. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 50. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 51. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 52. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 61. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 63. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 64. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 65. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 66. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Asia Pacific Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. Asia Pacific Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Asia Pacific Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Asia Pacific Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Asia Pacific Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Asia Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. Asia Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Asia Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Asia Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Asia Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Asia Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. Asia Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Asia Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Asia Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Asia Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. RoAPAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. RoAPAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. RoAPAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. RoAPAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. RoAPAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Leading 10 Batten Disease Treatment Market Companies (Ranking, Company, Latest Total Company Sales US$M, HQ)
Table 173. ReGenX Biosciences LLC Profile 2020 (CEO, HQ, Founded, Website)
Table 174. ReGenX Biosciences LLC Batten Disease Treatment Recent Developments
Table 175. ReGenX Biosciences LLC Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 176. BioMarin Pharmaceuticals Profile 2020 (CEO, HQ, Founded, Website)
Table 177. BioMarin Pharmaceuticals Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 178. Seneb BioSciences, Inc. Profile 2020 (CEO, HQ, Founded, Website)
Table 179. Seneb BioSciences, Inc. Batten Disease Treatment Recent Developments
Table 180. Seneb BioSciences, Inc. Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 181. Amicus Therapeutics Profile 2020 (CEO, HQ, Founded, Website)
Table 182. Amicus Therapeutics Batten Disease Treatment Recent Developments
Table 183. Amicus Therapeutics Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 184. Abeona Therapeutics Profile 2020 (CEO, HQ, Founded, Website)
Table 185. Abeona Therapeutics Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 186. Polaryx Therapeutics Company Profile 2020 (CEO, HQ, Founded, Website)
Table 187. Polaryx Therapeutics Company Optic Network Recent Developments
Table 188. Polaryx Therapeutics Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 189. Theranexus Profile 2020 (CEO, HQ, Founded, Website)
Table 190. Theranexus Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 191. Recursion Pharmaceuticals Profile 2020 (CEO, HQ, Founded, Website)
Table 192. Recursion Pharmaceuticals Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 193. Sanofi Profile 2020 (CEO, HQ, Founded, Website)
Table 194. Sanofi Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 195. Takeda Pharmaceuticals Profile 2020 (CEO, Total Company Sales US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 196. Takeda Pharmaceuticals Total Company Sales 2015-2020 (US$m, AGR %)
Table 197. Takeda Pharmaceuticals Sales by Segment of Business 2020 (US$m)
Table 198. Other Companies Involved in the Batten Disease Treatment Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1. Batten Disease Treatment Market Disease Type Overview
Figure 2. Batten Disease Treatment Market Therapy Overview
Figure 3. Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 4. Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 5. Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 6. Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 7. Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 8. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 9. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 10. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 11. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 12. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 13. Late Infantile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 14. Late Infantile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 15. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 16. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 17. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 18. Juvenile NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 19. Juvenile NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 20. Juvenile NCL Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 21. Juvenile NCL Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 22. Juvenile NCL Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 23. Adult NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 24. Adult NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 25. Adult NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 26. Adult NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 27. Adult NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 28. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 29. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 30. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 31. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 32. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 33. Occupational Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 34. Occupational Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 35. Occupational Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 36. Occupational Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 37. Occupational Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 38. Physical Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 39. Physical Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 40. Physical Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 41. Physical Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 42. Physical Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 43. Regional Batten Disease Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 44. Regional Batten Disease Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 45. Regional Batten Disease Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 46. Regional Batten Disease Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 47. Regional Batten Disease Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 48. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 49. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 50. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 51. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 52. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 53. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %) (Before COVID)
Figure 54. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 55. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 56. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 57. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 58. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 59. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 60. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 61. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 62. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 63. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 64. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 65. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 66. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 67. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 68. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 69. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 70. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 71. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 72. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 73. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M)
Figure 74. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 75. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 76. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 77. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 78. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (Before COVID)
Figure 79. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario V)
Figure 80. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario U)
Figure 81. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario W)
Figure 82. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario L)
Figure 83. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 84. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 85. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 86. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 87. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 88. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 89. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 90. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 91. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 92. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 93. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 94. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 95. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 96. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 97. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 98. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 99. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 100. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 101. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 102. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 103. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 104. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 105. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 106. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 107. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 108. Asia-Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (Before COVID)
Figure 109. Asia-Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario V)
Figure 110. Asia-Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario U)
Figure 111. Asia-Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario W)
Figure 112. Asia-Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario L)
Figure 113. Asia-Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 114. Asia-Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 115. Asia-Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 116. Asia-Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 117. Asia-Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 118. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 119. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 120. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 121. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 122. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 123. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 124. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 125. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 126. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 127. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 128. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 129. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 130. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 131. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 132. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 133. Rest of APAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 134. Rest of APAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 135. Rest of APAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 136. Rest of APAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 137. Rest of APAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 138. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M)
Figure 139. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 140. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 141. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 142. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 143. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (Before COVID)
Figure 144. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario V)
Figure 145. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario U)
Figure 146. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario W)
Figure 147. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario L)
Figure 148. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M)
Figure 149. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 150. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 151. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 152. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 153. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (Before COVID)
Figure 154. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario V)
Figure 155. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario U)
Figure 156. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario W)
Figure 157. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario L)
Figure 158. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M)
Figure 159. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 160. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 161. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 162. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 163. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (Before COVID)
Figure 164. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario V)
Figure 165. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario U)
Figure 166. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario W)
Figure 167. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario L)
Figure 168. Porter’s Five Force Analysis
Companies Mentioned
1. ReGenX Biosciences LLC
2. BioMarin Pharmaceuticals
3. Seneb BioSciences Inc.
4. Amicus Therapeutics
5. Abeona Therapeutics
6. Polaryx Therapeutics
7. Theranexus
8. Recursion Pharmaceuticals
9. Sanofi
10. Takeda Pharmaceuticals
11. StemCells, Inc.
12. Antech Diagnostics
13. Neurogene Inc.
14. Celgene Corp
15. Raptor Pharmaceutical Corp
16. Spark Therapeutics Inc
17. Blue Turtle Bio Technologies Inc
18. Circumvent Pharmaceuticals Inc
19. Polaryx Therapeutics Inc
20. Retrotope Inc
21. Seneb BioSciences Inc
22. Xonovo Inc
23. Collaborations Pharmaceuticals Inc
24. Exicure Inc
25. Polaryx Therapeutics Inc
26. Theranexus SAS
27. Pfizer, Inc.
28. F. Hoffman-La Roche AG
29. Bristol-Myers Squibb Company
30. Eli Lilly and Company
31. Novartis AG
32. Mylan N.V.
33. Kyowa Hakko Kirin Co Ltd.
34. Intercept Pharmaceuticals, Inc.
35. Accord Healthcare Inc.
36. Delcath Systems Inc.
37. Johnson & Johnson
38. Abbott Laboratories
39. AbbVie
40. Amgen
41. Astellas Pharma
42. AstraZeneca
43. Aurora Biophama
44. Boehringer Ingelheim
45. Bristol-Myers Squibb (BMS)
46. Gilead
47. GlaxoSmithKline (GSK)
48. Merck
49. GE Healthcare
50. Abbott Laboratories
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Batten Disease Treatment Market
2.1. Batten Disease Treatment Market Definition
2.2. Disease Type Submarkets Definitions
2.3. Therapy Submarkets Definitions
3. Batten Disease Treatment Market Overview
3.1. Global Batten Disease Treatment Market Size and Forecast by Region
3.2. Global Batten Disease Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising incidence and prevalence rate of batten disease
3.3.1.2. Robust investment in R&D
3.3.1.3. Cohesive government policies and initiatives
3.3.1.4. Technological Advancement and innovation
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost of Treatment and Therapies
3.3.2.2. Low awareness
3.3.3. Opportunities
3.3.3.1. Cohesive reimbursement policies
3.3.3.2. Healthcare reforms in emerging economies
3.3.3.3. Growing disposable income
4. Global Batten Disease Treatment Market Analysis and Forecast 2021-2031, by Disease Type(Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Late Infantile NCL
4.1.2. Juvenile NCL
4.1.3. Adult NCL
5. Global Batten Disease Treatment Market Analysis and Forecast, 2021-2031 by Therapy (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Occupational Therapy
5.1.2. Physical Therapy
6. North America Batten Disease Treatment Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Batten Disease Treatment Market Size and Forecast by Disease Type
6.3. North America Batten Disease Treatment Market Size and Forecast by Therapy
6.4. U.S. Batten Disease Treatment Market
6.4.1. Growing Incidence and Prevalence Rate of Batten Disease
6.5. Canada Batten Disease Treatment Market
6.5.1. Cohesive Healthcare Policies
7. Europe Batten Disease Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Batten Disease Treatment Market Size and Forecast by Disease Type
7.3. Europe Batten Disease Treatment Market Size and Forecast by Therapy
7.4. UK Batten Disease Treatment Market
7.5. Germany Batten Disease Treatment Market
7.6. France Batten Disease Treatment Market
7.7. Rest of Europe Batten Disease Treatment Market
8. Asia Pacific Batten Disease Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Batten Disease Treatment Market Size and Forecast by Disease Type
8.3. Asia Pacific Batten Disease Treatment Market Size and Forecast by Therapy
8.4. China Batten Disease Treatment Market
8.5. India Batten Disease Treatment Market
8.6. Japan Batten Disease Treatment Market
8.7. Rest of Asia Pacific Batten Disease Treatment Market
9. Latin America Batten Disease Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Batten Disease Treatment Market Size and Forecast by Disease Type
9.3. Latin America Batten Disease Treatment Market Size and Forecast by Therapy
9.3.1. Brazil Batten Disease Treatment Market
9.3.2. Mexico Batten Disease Treatment Market
9.3.3. Rest of Latin America Batten Disease Treatment Market
10. MEA Batten Disease Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Batten Disease Treatment Market Size and Forecast by Disease Type
10.3. MEA Batten Disease Treatment Market Size and Forecast by Therapy
10.4. GCC Batten Disease Treatment Market
10.5. South Africa Batten Disease Treatment Market
10.6. Rest of MEA Batten Disease Treatment Market
11. Companies in the Batten Disease Treatment Market
11.1. ReGenX Biosciences LLC
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial (2016-2020)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2020
11.1.4. Product Offerings
11.1.5. Recent Initiatives (2017-2020)
11.2. BioMarin Pharmaceuticals
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2020)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2020
11.2.4. Product Offerings
11.2.5. Recent Initiatives (2017-2020)
11.3. Seneb BioSciences Inc.
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2020)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2020
11.3.4. Product Offerings
11.3.5. Recent Initiatives (2017-2020)
11.4. Amicus Therapeutics
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance (2015-2020)
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue, 2020
11.4.4. Product Offerings
11.4.5. Recent Initiatives (2017-2020)
11.5. Abeona Therapeutics
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance (2015-2020)
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue, 2020
11.5.4. Product Offerings
11.5.5. Recent Initiatives (2017-2020)
11.6. Polaryx Therapeutics
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance (2015-2020)
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue, 2020
11.6.4. Product Offerings
11.6.5. Recent Initiatives (2017-2020)
11.7. Theranexus
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance (2015-2020)
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue, 2020
11.7.4. Product Offerings
11.7.5. Recent Initiatives (2017-2020)
11.8. Recursion Pharmaceuticals
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance (2015-2020)
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue, 2020
11.8.4. Product Offerings
11.8.5. Recent Initiatives (2017-2020)
11.9. Sanofi
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance (2015-2020)
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue, 2020
11.9.4. Product Offerings
11.9.5. Recent Initiatives (2017-2020)
11.10. Takeda Pharmaceuticals
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance (2015-2020)
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue, 2020
11.10.4. Product Offerings
11.10.5. Recent Initiatives (2017-2020)
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Type
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation Type
LIST OF TABLES
Table 1. Batten Disease Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Batten Disease Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Batten Disease Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Batten Disease Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Batten Disease Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Batten Disease Treatment Market Drivers & Restraints 2021
Table 7. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 13. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Juvenile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Juvenile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Juvenile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Juvenile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Juvenile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Adult NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Adult NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Adult NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Adult NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Adult NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 28. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Occupational Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Occupational Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Occupational Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Occupational Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Occupational Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Physical Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Physical Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Physical Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Physical Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Physical Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Regional Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 43. Regional Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Regional Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Regional Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Regional Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 47. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 48. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 49. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 50. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 51. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 52. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 61. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 63. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 64. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 65. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 66. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Asia Pacific Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. Asia Pacific Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Asia Pacific Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Asia Pacific Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Asia Pacific Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Asia Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. Asia Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Asia Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Asia Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Asia Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Asia Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. Asia Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Asia Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Asia Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Asia Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. RoAPAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. RoAPAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. RoAPAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. RoAPAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. RoAPAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Leading 10 Batten Disease Treatment Market Companies (Ranking, Company, Latest Total Company Sales US$M, HQ)
Table 173. ReGenX Biosciences LLC Profile 2020 (CEO, HQ, Founded, Website)
Table 174. ReGenX Biosciences LLC Batten Disease Treatment Recent Developments
Table 175. ReGenX Biosciences LLC Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 176. BioMarin Pharmaceuticals Profile 2020 (CEO, HQ, Founded, Website)
Table 177. BioMarin Pharmaceuticals Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 178. Seneb BioSciences, Inc. Profile 2020 (CEO, HQ, Founded, Website)
Table 179. Seneb BioSciences, Inc. Batten Disease Treatment Recent Developments
Table 180. Seneb BioSciences, Inc. Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 181. Amicus Therapeutics Profile 2020 (CEO, HQ, Founded, Website)
Table 182. Amicus Therapeutics Batten Disease Treatment Recent Developments
Table 183. Amicus Therapeutics Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 184. Abeona Therapeutics Profile 2020 (CEO, HQ, Founded, Website)
Table 185. Abeona Therapeutics Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 186. Polaryx Therapeutics Company Profile 2020 (CEO, HQ, Founded, Website)
Table 187. Polaryx Therapeutics Company Optic Network Recent Developments
Table 188. Polaryx Therapeutics Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 189. Theranexus Profile 2020 (CEO, HQ, Founded, Website)
Table 190. Theranexus Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 191. Recursion Pharmaceuticals Profile 2020 (CEO, HQ, Founded, Website)
Table 192. Recursion Pharmaceuticals Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 193. Sanofi Profile 2020 (CEO, HQ, Founded, Website)
Table 194. Sanofi Batten Disease Treatment Product Offering (Segment, Product Offerings)
Table 195. Takeda Pharmaceuticals Profile 2020 (CEO, Total Company Sales US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 196. Takeda Pharmaceuticals Total Company Sales 2015-2020 (US$m, AGR %)
Table 197. Takeda Pharmaceuticals Sales by Segment of Business 2020 (US$m)
Table 198. Other Companies Involved in the Batten Disease Treatment Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1. Batten Disease Treatment Market Disease Type Overview
Figure 2. Batten Disease Treatment Market Therapy Overview
Figure 3. Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 4. Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 5. Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 6. Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 7. Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 8. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 9. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 10. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 11. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 12. Batten Disease Treatment Submarket Forecast by Disease Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 13. Late Infantile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 14. Late Infantile NCL Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 15. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 16. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 17. Late Infantile NCL Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 18. Juvenile NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 19. Juvenile NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 20. Juvenile NCL Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 21. Juvenile NCL Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 22. Juvenile NCL Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 23. Adult NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 24. Adult NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 25. Adult NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 26. Adult NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 27. Adult NCL Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 28. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 29. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 30. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 31. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 32. Batten Disease Treatment Submarket Forecast by Therapy 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 33. Occupational Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 34. Occupational Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 35. Occupational Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 36. Occupational Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 37. Occupational Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 38. Physical Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 39. Physical Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 40. Physical Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 41. Physical Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 42. Physical Therapy Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 43. Regional Batten Disease Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 44. Regional Batten Disease Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 45. Regional Batten Disease Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 46. Regional Batten Disease Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 47. Regional Batten Disease Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 48. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 49. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 50. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 51. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 52. North America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 53. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %) (Before COVID)
Figure 54. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 55. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 56. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 57. North America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 58. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 59. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 60. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 61. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 62. North America Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 63. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 64. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 65. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 66. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 67. US Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 68. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 69. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 70. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 71. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 72. Canada Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 73. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M)
Figure 74. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 75. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 76. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 77. Europe Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 78. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (Before COVID)
Figure 79. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario V)
Figure 80. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario U)
Figure 81. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario W)
Figure 82. Europe Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario L)
Figure 83. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 84. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 85. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 86. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 87. Europe Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 88. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 89. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 90. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 91. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 92. UK Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 93. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 94. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 95. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 96. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 97. Germany Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 98. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 99. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 100. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 101. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 102. France Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 103. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 104. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 105. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 106. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 107. Rest of Europe Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 108. Asia-Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (Before COVID)
Figure 109. Asia-Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario V)
Figure 110. Asia-Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario U)
Figure 111. Asia-Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario W)
Figure 112. Asia-Pacific Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario L)
Figure 113. Asia-Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 114. Asia-Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 115. Asia-Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 116. Asia-Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 117. Asia-Pacific Batten Disease Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 118. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 119. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 120. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 121. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 122. China Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 123. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 124. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 125. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 126. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 127. India Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 128. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 129. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 130. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 131. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 132. Japan Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 133. Rest of APAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 134. Rest of APAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 135. Rest of APAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 136. Rest of APAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 137. Rest of APAC Batten Disease Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 138. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M)
Figure 139. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 140. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 141. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 142. Middle East Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 143. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (Before COVID)
Figure 144. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario V)
Figure 145. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario U)
Figure 146. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario W)
Figure 147. Middle East Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario L)
Figure 148. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M)
Figure 149. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 150. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 151. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 152. Latin America Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 153. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (Before COVID)
Figure 154. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario V)
Figure 155. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario U)
Figure 156. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario W)
Figure 157. Latin America Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario L)
Figure 158. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M)
Figure 159. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 160. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 161. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 162. Africa Batten Disease Treatment Market Forecast by Disease Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 163. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (Before COVID)
Figure 164. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario V)
Figure 165. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario U)
Figure 166. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario W)
Figure 167. Africa Batten Disease Treatment Market Forecast by Therapy 2021-2031 (US$M) (COVID - Scenario L)
Figure 168. Porter’s Five Force Analysis
Companies Mentioned
1. ReGenX Biosciences LLC
2. BioMarin Pharmaceuticals
3. Seneb BioSciences Inc.
4. Amicus Therapeutics
5. Abeona Therapeutics
6. Polaryx Therapeutics
7. Theranexus
8. Recursion Pharmaceuticals
9. Sanofi
10. Takeda Pharmaceuticals
11. StemCells, Inc.
12. Antech Diagnostics
13. Neurogene Inc.
14. Celgene Corp
15. Raptor Pharmaceutical Corp
16. Spark Therapeutics Inc
17. Blue Turtle Bio Technologies Inc
18. Circumvent Pharmaceuticals Inc
19. Polaryx Therapeutics Inc
20. Retrotope Inc
21. Seneb BioSciences Inc
22. Xonovo Inc
23. Collaborations Pharmaceuticals Inc
24. Exicure Inc
25. Polaryx Therapeutics Inc
26. Theranexus SAS
27. Pfizer, Inc.
28. F. Hoffman-La Roche AG
29. Bristol-Myers Squibb Company
30. Eli Lilly and Company
31. Novartis AG
32. Mylan N.V.
33. Kyowa Hakko Kirin Co Ltd.
34. Intercept Pharmaceuticals, Inc.
35. Accord Healthcare Inc.
36. Delcath Systems Inc.
37. Johnson & Johnson
38. Abbott Laboratories
39. AbbVie
40. Amgen
41. Astellas Pharma
42. AstraZeneca
43. Aurora Biophama
44. Boehringer Ingelheim
45. Bristol-Myers Squibb (BMS)
46. Gilead
47. GlaxoSmithKline (GSK)
48. Merck
49. GE Healthcare
50. Abbott Laboratories
Companies Profiled in the Report
1. ReGenX Biosciences LLC
2. BioMarin Pharmaceuticals
3. Seneb BioSciences, Inc.
4. Amicus Therapeutics
5. Abeona Therapeutics
6. Polaryx Therapeutics
7. Theranexus
8. Recursion Pharmaceuticals
9. Sanofi
10. Takeda Pharmaceuticals
11. StemCells, Inc.
12. Antech Diagnostics
13. Neurogene Inc.
14. Celgene Corp
List of Companies Mentioned in the Report
1. ReGenX Biosciences LLC
2. BioMarin Pharmaceuticals
3. Seneb BioSciences Inc.
4. Amicus Therapeutics
5. Abeona Therapeutics
6. Polaryx Therapeutics
7. Theranexus
8. Recursion Pharmaceuticals
9. Sanofi
10. Takeda Pharmaceuticals
11. StemCells, Inc.
12. Antech Diagnostics
13. Neurogene Inc.
14. Celgene Corp
15. Raptor Pharmaceutical Corp
16. Spark Therapeutics Inc
17. Blue Turtle Bio Technologies Inc
18. Circumvent Pharmaceuticals Inc
19. Polaryx Therapeutics Inc
20. Retrotope Inc
21. Seneb BioSciences, Inc
22. Xonovo Inc
23. Collaborations Pharmaceuticals Inc
24. Exicure Inc
25. Polaryx Therapeutics Inc
26. Theranexus SAS
27. Pfizer, Inc.
28. F. Hoffman-La Roche AG
29. Bristol-Myers Squibb Company
30. Eli Lilly and Company
31. Novartis AG
32. Mylan N.V.
33. Kyowa Hakko Kirin Co Ltd.
34. Intercept Pharmaceuticals, Inc.
35. Accord Healthcare Inc.
36. Delcath Systems Inc.
37. Johnson & Johnson
38. Abbott Laboratories
39. AbbVie
40. Amgen
41. Astellas Pharma
42. AstraZeneca
43. Aurora Biophama
44. Boehringer Ingelheim
45. Bristol-Myers Squibb (BMS)
46. Gilead
47. GlaxoSmithKline (GSK)
48. Merck
49. GE Healthcare
50. Abbott Laboratories
List of Organizations Mentioned in the Report
1. NCBI (National Center for Biotechnology Information)
2. Beyondbatten.org
3. World Health Organization (WHO)
4. BDSRA
5. Raredisease.org
6. Brain foundation
7. Brainfact.org
8. European Commission
9. World Bank
10. BDFA
11. Charlotte & Gwenyth Gray Foundation
12. Biotech trade organizations
13. Biotech innovation organizations
14. Centers for Disease Control and Prevention (CDC)
15. National Institutes of Health (NIH)
16. Free Patent Online
17. Clinicaltrial.gov
18. Cleveland Clinic
19. Texaschildren.org
20. Batten Disease Support and Research Association Australia
1. ReGenX Biosciences LLC
2. BioMarin Pharmaceuticals
3. Seneb BioSciences, Inc.
4. Amicus Therapeutics
5. Abeona Therapeutics
6. Polaryx Therapeutics
7. Theranexus
8. Recursion Pharmaceuticals
9. Sanofi
10. Takeda Pharmaceuticals
11. StemCells, Inc.
12. Antech Diagnostics
13. Neurogene Inc.
14. Celgene Corp
List of Companies Mentioned in the Report
1. ReGenX Biosciences LLC
2. BioMarin Pharmaceuticals
3. Seneb BioSciences Inc.
4. Amicus Therapeutics
5. Abeona Therapeutics
6. Polaryx Therapeutics
7. Theranexus
8. Recursion Pharmaceuticals
9. Sanofi
10. Takeda Pharmaceuticals
11. StemCells, Inc.
12. Antech Diagnostics
13. Neurogene Inc.
14. Celgene Corp
15. Raptor Pharmaceutical Corp
16. Spark Therapeutics Inc
17. Blue Turtle Bio Technologies Inc
18. Circumvent Pharmaceuticals Inc
19. Polaryx Therapeutics Inc
20. Retrotope Inc
21. Seneb BioSciences, Inc
22. Xonovo Inc
23. Collaborations Pharmaceuticals Inc
24. Exicure Inc
25. Polaryx Therapeutics Inc
26. Theranexus SAS
27. Pfizer, Inc.
28. F. Hoffman-La Roche AG
29. Bristol-Myers Squibb Company
30. Eli Lilly and Company
31. Novartis AG
32. Mylan N.V.
33. Kyowa Hakko Kirin Co Ltd.
34. Intercept Pharmaceuticals, Inc.
35. Accord Healthcare Inc.
36. Delcath Systems Inc.
37. Johnson & Johnson
38. Abbott Laboratories
39. AbbVie
40. Amgen
41. Astellas Pharma
42. AstraZeneca
43. Aurora Biophama
44. Boehringer Ingelheim
45. Bristol-Myers Squibb (BMS)
46. Gilead
47. GlaxoSmithKline (GSK)
48. Merck
49. GE Healthcare
50. Abbott Laboratories
List of Organizations Mentioned in the Report
1. NCBI (National Center for Biotechnology Information)
2. Beyondbatten.org
3. World Health Organization (WHO)
4. BDSRA
5. Raredisease.org
6. Brain foundation
7. Brainfact.org
8. European Commission
9. World Bank
10. BDFA
11. Charlotte & Gwenyth Gray Foundation
12. Biotech trade organizations
13. Biotech innovation organizations
14. Centers for Disease Control and Prevention (CDC)
15. National Institutes of Health (NIH)
16. Free Patent Online
17. Clinicaltrial.gov
18. Cleveland Clinic
19. Texaschildren.org
20. Batten Disease Support and Research Association Australia
Download sample pages
Complete the form below to download your free sample pages for Batten Disease Treatment Market Report to 2031Download sample pages
Complete the form below to download your free sample pages for Batten Disease Treatment Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033
The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033
31 May 2023
Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
26 May 2023
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023
